Omnicell Inc (OMCL)
30.80
+0.68
(+2.26%)
USD |
NASDAQ |
May 13, 16:00
30.82
+0.02
(+0.06%)
After-Hours: 20:00
Omnicell Price to Book Value: 1.19 for May 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 13, 2024 | 1.19 |
| May 10, 2024 | 1.164 |
| May 09, 2024 | 1.169 |
| May 08, 2024 | 1.158 |
| May 07, 2024 | 1.171 |
| May 06, 2024 | 1.158 |
| May 03, 2024 | 1.164 |
| May 02, 2024 | 1.132 |
| May 01, 2024 | 1.050 |
| April 30, 2024 | 1.036 |
| April 29, 2024 | 1.059 |
| April 26, 2024 | 1.076 |
| April 25, 2024 | 1.048 |
| April 24, 2024 | 1.060 |
| April 23, 2024 | 1.098 |
| April 22, 2024 | 1.089 |
| April 19, 2024 | 1.075 |
| April 18, 2024 | 1.053 |
| April 17, 2024 | 1.015 |
| April 16, 2024 | 1.030 |
| April 15, 2024 | 1.039 |
| April 12, 2024 | 1.050 |
| April 11, 2024 | 1.056 |
| April 10, 2024 | 1.060 |
| April 09, 2024 | 1.107 |
| Date | Value |
|---|---|
| April 08, 2024 | 1.078 |
| April 05, 2024 | 1.063 |
| April 04, 2024 | 1.066 |
| April 03, 2024 | 1.065 |
| April 02, 2024 | 1.072 |
| April 01, 2024 | 1.106 |
| March 31, 2024 | |
| March 28, 2024 | 1.129 |
| March 27, 2024 | 1.129 |
| March 26, 2024 | 1.077 |
| March 25, 2024 | 1.097 |
| March 22, 2024 | 1.079 |
| March 21, 2024 | 1.098 |
| March 20, 2024 | 1.079 |
| March 19, 2024 | 1.068 |
| March 18, 2024 | 1.061 |
| March 15, 2024 | 1.070 |
| March 14, 2024 | 1.066 |
| March 13, 2024 | 1.072 |
| March 12, 2024 | 1.084 |
| March 11, 2024 | 1.092 |
| March 08, 2024 | 1.103 |
| March 07, 2024 | 1.084 |
| March 06, 2024 | 1.073 |
| March 05, 2024 | 1.020 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.010
Minimum
Feb 28 2024
7.260
Maximum
Nov 23 2021
3.881
Average
3.871
Median
Sep 05 2019
Price to Book Value Benchmarks
| Teladoc Health Inc | 0.9224 |
| American Shared Hospital Services | 0.9765 |
| Novo Integrated Sciences Inc | 0.4938 |
| Astrana Health Inc | 2.720 |
| Cryo-Cell International Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1.273 |
| PEG Ratio | -4.464 |
| Price to Free Cash Flow | 8.530 |
| Price | 30.80 |
| Earnings Yield | -1.49% |
| Market Cap | 1.414B |
| PEGY Ratio | -4.464 |